CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene Therapy

PartnershipPositive
AI Analysis

Summary

Genprex selected a leading CDMO partner to accelerate manufacturing scale-up for its diabetes gene therapy program, supporting IND-enabling preclinical studies and future clinical trials.

Importance:5/10
Sentiment:
0.60
gene therapymanufacturingdiabetesCDMOIND-enabling studies
Related Companies

Read the original article

Published by PR Newswire Pharma on August 18, 2026 11:00 AM

Read Original